President Trump "is no longer considered a transmission risk to others" and "there is no longer evidence of actively replicating virus," White House physician Sean Conley said in a memorandum published Saturday.
Of note: The memo does not mention when Trump's last negative coronavirus test was, but it states that the president has been "fever-free for well over 24 hours and all symptoms improved."
Editor's note: This is a developing news story. Please check back for updates.
Watch for President Trump to address Joe Biden as “the big guy” or “the chairman” at tonight's debate as a way of dramatizing the Hunter Biden emails, Jonathan Swan tells me. Hunter's former business partner Tony Bobulinski is expected to be a Trump debate guest.
The big picture: Trump's advisers universally view the first debate as a catastrophe — evidenced by a sharp plunge in Trump’s public and (more convincingly for them) private polling immediately following the debate.
Shares of Intel fell as much 10% in after-hours trading Thursday — after the company posted quarterly revenue and earnings generally in line with expectations.
Why it matters: The chip giant is a bellwether for the PC industry, and small signs of weakness may be playing an outsize role in spooking investors.
Energetic Bear, a Russian state-sponsored hacking group, has stolen data from two servers after targeting state and federal government networks in the U.S. since at least September, the FBI and Cybersecurity and Infrastructure Security Agency said on Thursday.
Driving the news: Director of National Intelligence John Ratcliffe announced Wednesday that Iran and Russia had obtained voter registration information that could be used to undermine confidence in the U.S. election system.
Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.
Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.
It's still the early days of the coronavirus pandemic, but history, biology and the knowledge gained from our first nine months with COVID-19 point to how the pandemic might end.
The big picture: Pandemics don't last forever. But when they end, it usually isn't because a virus disappearsor is eliminated. Instead, they can settle into a population, becoming a constant background presence that occasionally flares up in local outbreaks.
Home prices are rising rapidly across the U.S., according to ATTOM Data Solutions.
Driving the news: ATTOM released its 3Q 2020 figures this week, concluding that 77% of metro areas posted "double-digit annual home price gains." Profit margins rose in 86% of the 103 metropolitan statistical areas studied.
Short-form video streaming app Quibi announced that it will cease operations, just six months after a high-profile launch backed by $1.75 billion in funding from studios and venture capitalists.
Axios Re:Cap digs into what went wrong and what happens next, with REDEF CEO Jason Hirschhorn.
A growing number of mayors are banding together to fight what they consider to be an inaccurate and abruptly curtailed 2020 census, using an arsenal of legal, legislative and congressional efforts.
Why it matters: The outcome may determine whether President Trump or Joe Biden controls the redistricting process, which governs everything from congressional representation and redistricting to funding for schools and Head Start.
